Sequenom, Inc.

Sequenom Reports Third Quarter 2009 Financial Results

Published in Lab Law Weekly, November 27th, 2009

with $11.6 million for the third quarter of 2008. -- Cost of product and service revenue for the third quarter of 2009 was

$2.7 million, compared with $4.5 million for the third quarter of

2008. -- Gross margin for the third quarter of 2009 was 71%, compared with 61%

for the third quarter of 2008, reflecting higher consumable sales as a

percentage of the company's product sales. -- Research and development expenses were $8.5 million for the third

quarter of 2009, compared with $7.1 million for the same period in the

prior year. Research and development expenses for the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2009-11-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry